ACDF Brief comments: The evolving role of SGLT2 inhibitors in heart failure?
Expert faculty provide brief commentaries on content related to the Asian Cardio Diabetes Forum 2019. Prof. Nikolaus Marx comments on the question how he thinks the role of SGLT-2 inhibitors would evolve in addressing heart failure?
Prof. Nikolaus Marx, MD Aachen, Germany. Prof. is Marx is Professor of Medicine / Cardiology and Head of the Department of Internal Medicine I, University Hospital Aachen, Germany
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The Asian Cardio Diabetes Forum was funded by Boehringer Ingelheim Singapore
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: